Lemonitsa H. Mammatas

Author

Also Known As

L H Mammatas, L. H. Mammatas, L. Mammatas, L.H. Mammatas, Lemonitsa H Mammatas, Lemonitsa H. Mammatas, Lemonitsa Hillegonda Mammatas, Lemonitsa Mammatas

Publications

255

Citations

H-Index

Concepts

All Affiliations

Reinier de Graaf Hospital Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam University Medical Centers University of Groningen Radboud University Medical Center

About

Lemonitsa H. Mammatas is an author at Reinier de Graaf Hospital specializing in pharmacotherapy, hepatology, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	19
2	Hepatology	1	1	19
3	Pharmacology	1	1	19
4	Clinical Pharmacology	1	1	19
5	Pharmacokinetics	1	1	19

Lemonitsa H. Mammatas

Publications

210

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients Joosje C. Baltussen, Nienke A. de Glas, Yara van Holstein, JAMA Network Open	2023	71
Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies Clasina M. Venema, Lemonitsa H. Mammatas, Carolina P. Schröder, Journal of Nuclear Medicine	2017	61
A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion Jonathan M. Riel, Godefridus J. Peters, Lemonitsa H. Mammatas, European Journal of Cancer HepatologyMedicineLiver PhysiologyPharmacokinetic StudyClinical Pharmacology	2009	19
Diagnostic Performance of [18F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer Ramsha Iqbal, Lemonitsa H. Mammatas, Tuba Aras, Diagnostics	2021	19
Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study Lemonitsa H. Mammatas, Clasina M. Venema, Carolina P. Schröder, EJNMMI Research	2020	16
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study Lemonitsa H. Mammatas, Anthe S. Zandvliet, Maria Rovithi, Cancer Chemotherapy and Pharmacology	2020	14
Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Results from the bladder cohort of the DESTINY-PanTumor02 (DP-02) study. Piotr J. Wysocki, Kyung Hae Jung, Do‐Youn Oh, Journal of Clinical Oncology	2024	10

Page 1